Meet Eli Lilly’s New Phase 3 Alzheimer’s Drug, Remternetug
By
Simon Spichak, MSc
| December 9th, 2022
Drugmaker Eli Lilly says experimental Alzheimer’s drug remternetug is part of the next generation of anti-amyloids. The approval of the controversial anti-amyloid drug Aduhelm…